Treatment Options for Cluster Headache
For cluster headaches, high-flow oxygen therapy (12-15 L/min via a non-rebreather mask) is recommended as first-line treatment for acute attacks, followed by subcutaneous sumatriptan (6 mg) if oxygen is ineffective or unavailable. 1, 2
Acute Treatment Options
First-Line Treatments
High-flow oxygen therapy:
Subcutaneous sumatriptan:
Second-Line Treatment
- Intranasal zolmitriptan:
Preventive Treatment Options
First-Line Preventive Therapy
- Galcanezumab:
Additional Preventive Options
Verapamil:
Corticosteroids (short-term bridging therapy):
Non-invasive vagus nerve stimulation:
Alternative preventive options (when first-line treatments fail):
Treatment Algorithm
For acute attacks:
- Start with high-flow oxygen (12-15 L/min) via non-rebreather mask for 15 minutes
- If oxygen is unavailable or ineffective, use subcutaneous sumatriptan 6 mg
- If both are contraindicated, consider intranasal zolmitriptan 10 mg
For prevention during cluster periods:
- For episodic cluster headache: Initiate galcanezumab
- Consider verapamil (≥240 mg daily) with appropriate cardiac monitoring
- Use corticosteroids as bridging therapy until preventive medications take effect
For inadequate response:
- Consider non-invasive vagus nerve stimulation for episodic cluster headache
- Evaluate for greater occipital nerve blocks
- Consider alternative preventives like lithium or topiramate
Important Clinical Considerations
- Patients should begin treatment immediately at the onset of an attack for maximum effectiveness 1
- Patients with episodic cluster headache should have home oxygen arranged with provision for urgent installation when a cluster period begins 1
- Avoid alcohol during cluster periods as it is a common trigger 1
- Galcanezumab should not be used for chronic cluster headache 2, 1
- Patients should be educated about the importance of having rescue medication readily available during cluster periods 1
Monitoring and Follow-up
- Monitor cardiac function in patients using verapamil (ECG before initiation and with dose increases)
- Evaluate treatment efficacy regularly and adjust therapy as needed
- Consider transitioning from bridging therapy to long-term preventive treatment as appropriate